Angewandte Chemie International Edition

Cover image for Vol. 55 Issue 36

Editor: Peter Gölitz, Deputy Editors: Neville Compton, Haymo Ross

Online ISSN: 1521-3773

Associated Title(s): Angewandte Chemie, Chemistry - A European Journal, Chemistry – An Asian Journal, ChemistryOpen, ChemPlusChem, Zeitschrift für Chemie

Press Release

Angewandte Chemie International Edition 2006, 45, 4815–4819
doi: 10.1002/anie.200600073

Nr. 27/2006

Two-Stage Amplifier

Coupling two enzymatic reactions: sensitive detection for immunological ELISA tests

Contact: Itamar Willner, The Hebrew University of Jerusalem (Israel)
Registered journalists may download the original article here:
Biocatalytic Evolution of a Biocatalyst Marker: Towards the Ultrasensitive Detection of Immunocomplexes and DNA Analysis

Bioanalytical and diagnostic test methods are often based on the recognition of biomolecules by other biomolecules. However, biochemical events such as these are not directly detectable and must first be converted into physical signals, for example an electrical or optical signal. Since transient and minute amounts of substance are usually involved, which must be detected in very small test volumes, an effective "amplifier" must be employed. Enzyme reactions are a good choice as amplifiers and signal transformers: a single enzyme molecule generates a large number of detectable (e.g. fluorescent) molecules, which can be detected easily. This principle is also the basis of a well-established method, the enzyme-labeled immunosorbant assay (ELISA). Researchers in Jerusalem have now developed a new ELISA protocol that utilizes two successive enzyme reactions. Enzyme 1 produces many copies of enzyme 2, which in turn produces many copies of a detectable fluorescent dye. In this way, the amplification effect is increased, and the assay is much more sensitive. The research group of Itamar Willner has used this new protocol to develop an ELISA test for telomerase, an important cancer marker. In comparison with traditional telomerase assays, the new method is considerably simpler, more efficient, and more sensitive.

This is how it works: Anti-telomerase antibodies are immobilized on a carrier, to which the test sample is added. The telomerase in the sample adheres to the antibodies. In the next step, another telomerase antibody is added, which recognizes the bound telomerase and binds to it. The trick: this second antibody is fitted with a binding site for a molecular "adaptor". An ecarin enzyme fitted with such an adapter can thus bind to it. Now, the two-stage amplifier can kick in: ecarin converts added prothrombin into thrombin (a reaction that incidentally plays a role in blood clotting). Thrombin is a biocatalyst that is able to liberate the fluorescent dye rhodamine from a nonfluorescent precursor. By measuring the fluorescence, the researchers were able to detect the telomerase from only 1000 cancer cells—an amount that is not detectable using previous detection methods.

The method of nonlinear amplification through coupled enzyme reactions is not only suitable for immunoassays but also for the detection of specific DNA sequences.

(2469 characters)